Great Point Partners Invests in Tergus Pharma
June 7, 2019
Great Point Partners completed a growth recapitalization of Raleigh-based Tergus Pharma to fund construction of a new 100,000 square-foot commercial manufacturing facility for topical dermatology pharmaceuticals. The investment will expand Tergus' clinical and commercial manufacturing capacity and enable the company to offer end-to-end formulation, testing, and manufacturing services.
- Buyers
- Great Point Partners
- Targets
- Tergus Pharma
- Industry
- Pharmaceuticals
- Location
- North Carolina, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.